Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma
- 8 July 2009
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2011 (3) , CD006480
Abstract
Background Allergen exposure is one of the environmental factors seemingly associated with the development of asthma. If asthma is a multi‐factorial disease, it is hypothesised that prevention might only prove effective if most or all relevant environmental factors are simultaneously avoided. Objectives To assess effect(s) of monofaceted and multifaceted interventions compared with control interventions in preventing asthma and asthma symptoms in high risk children. Search methods We searched the Cochrane Airways Trials Register (January 2011). Selection criteria Randomised controlled trials of allergen exposure reduction for the primary prevention of asthma in children. Interventions were multifaceted (reducing exposure to both inhalant and food allergens) or monofaceted (reducing exposure to either inhalant or food allergens) Follow up had to be from birth (or during pregnancy) up to a minimum of two years of age. Data collection and analysis We included in the analysis studies assessing the primary outcome (current diagnosis: asthma) and/or one of the secondary outcomes (current respiratory symptoms: wheezing, nocturnal coughing and dyspnoea). We pooled multifaceted and monofaceted intervention trials separately. We made an indirect comparison of their effects using tests for interaction to calculate relative odds ratios. Main results We included three multifaceted and six monofaceted intervention studies (3271 children). Physician diagnosed asthma in children less than five years, and asthma as defined by respiratory symptoms and lung function criteria in children aged five years and older, both favoured treatment with a multifaceted intervention compared to usual care (< 5 years: odds ratio (OR) 0.72, 95% confidence interval (CI) 0.54 to 0.96, and > 5 years: OR 0.52, 95% CI 0.32 to 0.85). However, there was no significant difference in outcome between monofaceted intervention and control interventions (< 5 years: OR 1.12, 95% CI 0.76 to 1.64, and > 5 years: OR 0.83, 95% CI 0.59 to 1.16). Indirect comparison between these treatments did not demonstrate a significant difference between multiple interventions and mono‐interventions in reducing the frequency of asthma diagnosis in children under five years (relative OR 0.64 (95% CI 0.40 to 1.04, P = 0.07) or five years and older (relative OR 0.63, 95% CI 0.35 to 1.13, P = 0.12). There was also no significant difference between either mono‐ and multifaceted intervention and control in reducing the likelihood of symptoms of nocturnal coughing at follow up. Wheezing, however, showed a significant difference between multifaceted and mono‐interventions (relative OR 0.59, 95% CI 0.35 to 0.99, P = 0.04), but the significance was lost when data on treatment only was analysed. Authors' conclusions The available evidence suggests that the reduction of exposure to multiple allergens compared to usual care reduces the likelihood of a current diagnosis of asthma in children (at ages < 5 years and 5 years and older). Mono‐intervention studies have not produced effects which are statistically significant compared with control. In children who are at risk of developing childhood asthma, multifaceted interventions, characterised by dietary allergen reduction and environmental remediation, reduce the odds of a physician diagnosis of asthma later in childhood by half. This translates to a number needed to treat (NNT) of 17. The effect of multi‐faceted interventions on parent reported wheeze was inconsistent and had no significant impact on nocturnal coughing or dyspnoea. Data from monofaceted intervention exposed children studies were not significantly different from those of control groups for all outcomes. There remains uncertainty as to whether multiple interventions are more effective than mono‐component interventions. The comparisons made were indirect, making the conclusions drawn uncertain. To our knowledge there are no ongoing studies in which both intervention strategies are randomly compared. The findings, however, warrant further direct comparison between multiple‐ and monofaceted interventions aimed at reducing the prevalence of asthma in children.Keywords
This publication has 46 references indexed in Scilit:
- House dust mite allergen reduction and allergy at 4 yr: Follow up of the PIAMA‐studyPediatric Allergy and Immunology, 2006
- The Canadian Childhood Asthma Primary Prevention Study: Outcomes at 7 years of ageJournal of Allergy and Clinical Immunology, 2005
- The primary prevention of asthma in children study: Design of a multifaceted prevention programPediatric Allergy and Immunology, 2005
- The PREVASC study: the clinical effect of a multifaceted educational intervention to prevent childhood asthmaEuropean Respiratory Journal, 2005
- Effectiveness of and compliance to intervention measures in reducing house dust and cat allergen levelsAnnals of Allergy, Asthma & Immunology, 2002
- The Childhood Asthma Prevention Study (CAPS)Controlled Clinical Trials, 2001
- Long-term prevention of allergic diseases by using protein hydrolysate formula in at-risk infantsThe Journal of Pediatrics, 1992
- REDUCTION OF BRONCHIAL HYPERREACTIVITY DURING PROLONGED ALLERGEN AVOIDANCEThe Lancet, 1982
- PROLONGED BREAST-FEEDING AS PROPHYLAXIS FOR ATOPIC DISEASEThe Lancet, 1979
- Soy versus cow's milk in infants with a biparental history of atopic disease: development of atopic disease and immunoglobulins from birth to 4 years of ageClinical & Experimental Allergy, 1979